merck glp 1 agonist Comparing Ozempic, Wegovy and Other GLP-1 Drugs GLP-1 receptor agonists and next-generation
Description
S2: Peptide Hormones and Growth Factors - New EPO Mimetic Pegmolesatide was added as a new erythropoietin (EPO) mimetic agent
Lancet 398, 143155 (2021)
This is to allow elimination of the glucocorticoid to below the reporting level
Wonki K, Kim JA, Lee SH, Bae S, Choi IY, Kim YH
Ryan Cheu, current Director of Chemistry.
A., Eslaminejad, T., & Nematollahi-Mahani, S
